Correlation Between Lantern Pharma and Ibio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lantern Pharma and Ibio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lantern Pharma and Ibio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lantern Pharma and Ibio Inc, you can compare the effects of market volatilities on Lantern Pharma and Ibio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lantern Pharma with a short position of Ibio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lantern Pharma and Ibio.

Diversification Opportunities for Lantern Pharma and Ibio

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Lantern and Ibio is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Lantern Pharma and Ibio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ibio Inc and Lantern Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lantern Pharma are associated (or correlated) with Ibio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ibio Inc has no effect on the direction of Lantern Pharma i.e., Lantern Pharma and Ibio go up and down completely randomly.

Pair Corralation between Lantern Pharma and Ibio

Given the investment horizon of 90 days Lantern Pharma is expected to under-perform the Ibio. But the stock apears to be less risky and, when comparing its historical volatility, Lantern Pharma is 1.29 times less risky than Ibio. The stock trades about -0.04 of its potential returns per unit of risk. The Ibio Inc is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  188.00  in Ibio Inc on September 3, 2024 and sell it today you would earn a total of  106.00  from holding Ibio Inc or generate 56.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Lantern Pharma  vs.  Ibio Inc

 Performance 
       Timeline  
Lantern Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lantern Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Ibio Inc 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Ibio Inc are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Ibio displayed solid returns over the last few months and may actually be approaching a breakup point.

Lantern Pharma and Ibio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lantern Pharma and Ibio

The main advantage of trading using opposite Lantern Pharma and Ibio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lantern Pharma position performs unexpectedly, Ibio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ibio will offset losses from the drop in Ibio's long position.
The idea behind Lantern Pharma and Ibio Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Volatility Analysis
Get historical volatility and risk analysis based on latest market data